BLTE
BELITE BIO INC - ADR Earnings Dividend
$155.21
Earnings Summary
Revenue | $0Mn |
Net Profits | $-25.32Mn |
Net Profit Margins | -Inf% |
BELITE BIO INC - ADR’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, BELITE BIO INC - ADR has generated NaN% jump in its revenue since last 3-months.
BELITE BIO INC - ADR’s net profit fell -150.73% since last year same period to $-25.32Mn in the Q4 2025. On a quarterly growth basis, BELITE BIO INC - ADR has generated -16.75% fall in its net profits since last 3-months.
BELITE BIO INC - ADR’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, BELITE BIO INC - ADR has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.48 |
EPS Estimate Current Year | -0.48 |
BELITE BIO INC - ADR’s earning per share (EPS) estimates for the current quarter stand at -0.48 - a 3.02% jump from last quarter’s estimates.
BELITE BIO INC - ADR’s earning per share (EPS) estimates for the current year stand at -0.48.
Key Ratios
Earning Per Share (EPS) | -0.7 |
BELITE BIO INC - ADR’s earning per share (EPS) fell -118.75% since last year same period to -0.7 in the Q4 2025. This indicates that the BELITE BIO INC - ADR has generated -118.75% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-06-30 | -0.39 | -0.31 | 20.51% |
2025-03-31 | -0.37 | -0.27 | 27.03% |
2025-12-01 | -0.5 | -0.65 | -30.65% |
2026-03-31 | -0.48 | -0.7 | -45.08% |
